Holen Sie sich die Stockscreener-App
5.93
1.82%
-0.11
Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten
Cumberland outlines new product expansion and sees $8.3M Q3 revenues while advancing clinical pipeline - MSN
Cumberland Pharmaceuticals Sells Branded Drug Portfolio to Apotex for $100M, Refocuses on Rare Disease Pipeline 1 - Minichart
CPIXCumberland Pharmaceuticals Inc Latest SEC Filings - Finviz
Cumberland Refocuses on Rare Disease Pipeline After Asset Sale - TipRanks
Cumberland (CPIX) nets $100M from Apotex deal, shifts to rare disease pipeline - Stock Titan
Cumberland Pharmaceuticals closes $100 million sale of drug portfolio - The Business Journals
Cumberland sells branded drug portfolio to Apotex for $100m By Investing.com - Investing.com South Africa
Cumberland sells branded drug portfolio to Apotex for $100m - Investing.com
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals - The Globe and Mail
Cumberland sells branded U.S. drugs to Apotex for $100M - Stock Titan
Cumberland Pharma advances Duchenne program with new safety, efficacy data - MSN
Cumberland Pharma Advances Duchenne Program With New Safety, Efficacy Data - Sahm
Cumberland shares updated trial results for DMD heart therapy - Investing.com UK
Why Is Cumberland Pharma Stock Gaining Friday?Cumberland Pharma (NASDAQ:CPIX) - Benzinga
Cumberland says updated DMD heart data strengthen ifetroban case - Stock Titan
Cumberland Pharmaceuticals Inc (CPIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Shareholders back Cumberland (NASDAQ: CPIX) sale of most assets - Stock Titan
Cumberland Pharmaceuticals Inc (CPIX) Institutional Confidence - TradingKey
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement - Sahm
RedHill closes $6M financing, with up to $13.4M more possible - Stock Titan
Cumberland Pharmaceuticals Inc (CPIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
RedHill Biopharma raises $6M now, with $13.4M more tied to warrants - Stock Titan
Cumberland Pharmaceuticals Inc - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CPIX News | CUMBERLAND PHARMACEUTICALS (NASDAQ:CPIX) - ChartMill
CPIX Q1 2026 Earnings: Narrowing Losses Amidst Operational UncertaintyEPS Surprise History - newsline.com
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Brown Martin S JR - Moomoo
Cumberland Pharmaceuticals (CPIX) Slips 0.79% as Stock Hovers Near Key Support LevelFundamentals - dars.gov.et
RedHill moves to enforce $10.9M New York judgment on Kukbo in Korea - Stock Titan
Cumberland Pharmaceuticals (CPIX) Extends Decline Amid Low Volume PressurePrice Target - newsline.com
Cumberland shares soar on $100M deal announcement - Nashville Post
Cumberland reports positive phase 2a cancer trial results - Investing.com UK
Cumberland reports positive phase 2a cancer trial results By Investing.com - Investing.com Canada
Cumberland Pharmaceuticals And Vanderbilt Announce Phase 2A Trial Data For ifetroban In High-Risk Solid Tumors - TradingView
Early trial hints at drug to cut risk of cancer returning after treatment - Stock Titan
Pilot Study Demonstrates Safety of Ifetroban for Patients With High-Risk Solid Tumors, Suggests Potential to Block Cancer Metastasis | Newswise - Newswise
Cumberland Pharmaceuticals (CPIX) Rises 2.84%: Support Holds as Stock Approaches ResistanceTrend Following Picks - dars.gov.et
Cumberland Pharmaceuticals (CPIX) Gains Momentum: Up 2.84% on Normal Trading ActivityIV Percentile - The Legal Advocate
Cumberland Pharma Stock Rises After China Antibiotic Launch — Why Investors Are Watching - Bez Kabli
Cumberland Pharmaceuticals Hits New 52-Week High of $6.51 - MarketsMojo
CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV® IN CHINA - Citizen Tribune
Number of shareholders of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView
The Zacks Analyst Blog Highlights Alphabet, Apple, Micron Technology, Cumberland Pharmaceuticals and AmeriServ Financial - Yahoo Finance
New MRSA-fighting antibiotic Vibativ now available to patients in China - Stock Titan
CPIX Q1 2026 Earnings: Net Loss Reported, Shares Edge HigherGuidance Revision Trend - The Legal Advocate
CPIX Q1 2026 Earnings: Narrowing Losses and Strategic Progress Amidst Revenue ChallengesDividend Increase Stocks - The Legal Advocate
Cumberland Pharmaceuticals(CPIX) Stock Options Chain | Quotes & News - Moomoo
$Cumberland Pharmaceuticals (CPIX.US)$ Soaring!!!! - Moomoo
Cumberland Pharmaceuticals (NASDAQ: CPIX) to divest marketed brands to Apotex for $100M - Stock Titan
- The Legal Advocate
CPIX Q1 2026 Earnings: Loss Per Share of $0.13 as Stock Rebounds 6.5%Guidance Upgrade Report - newsline.com
Cumberland Pharmaceuticals jumps on $100M Apotex transaction - MSN
Cumberland Pharmaceuticals (CPIX) to sell U.S. brands to Apotex for $100M - Stock Titan
3.42%
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):